<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>WHO</title>
	<atom:link href="https://www.worldpharmatoday.com/topics/who/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Tue, 22 Jul 2025 10:40:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>WHO</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Nipah Virus Vaccines Enter Clinical Trials in Bangladesh</title>
		<link>https://www.worldpharmatoday.com/news/nipah-virus-vaccines-enter-clinical-trials-in-bangladesh/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 22 Jul 2025 10:40:27 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Humanitarian Aid]]></category>
		<category><![CDATA[Vaccination]]></category>
		<category><![CDATA[WHO]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/nipah-virus-vaccines-enter-clinical-trials-in-bangladesh/</guid>

					<description><![CDATA[<p>Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection. While Nipah case numbers remain low, climate change is shifting habitats, bringing fruit bats that transmit and spread the virus in South and [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/news/nipah-virus-vaccines-enter-clinical-trials-in-bangladesh/">Nipah Virus Vaccines Enter Clinical Trials in Bangladesh</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Clinical Trial Supplies Market Worth $8.18 Billion by 2030</title>
		<link>https://www.worldpharmatoday.com/industry-reports/clinical-trial-supplies-market-worth-8-18-billion-by-2030/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 04 Jul 2025 07:10:56 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Industry Reports]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[WHO]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/clinical-trial-supplies-market-worth-8-18-billion-by-2030/</guid>

					<description><![CDATA[<p>The market for clinical trial supplies is about to change a lot because there is a growing need for new ways to help people with their health and because medical research is making progress. As the world changes, the clinical trials market is anticipated to reach USD 8.18 billion in 2030 from USD 5.34 billion [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/industry-reports/clinical-trial-supplies-market-worth-8-18-billion-by-2030/">Clinical Trial Supplies Market Worth $8.18 Billion by 2030</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
